News
New York Post on MSN21h
Grandmother given ‘second chance’ after world-first heart valve operationJulia had an issue with her tricuspid valve and the type of replacements that were available were not suitable for her, as ...
The global flurry of innovation in tricuspid valve interventions continues in the wake of Evoque's release, as illustrated by ...
If you have severe tricuspid valve regurgitation, doctors may recommend repair or replacement surgery. The tricuspid valve is one of four valves in your heart’s four chambers. It’s on the ...
The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...
Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.
Another prespecified outcome of the trial, 2-year freedom from all-cause mortality, tricuspid valve surgery, and tricuspid valve intervention, also greatly favored TEER (77.6% vs 29.3% ...
Medical Xpress on MSN20d
Minimally invasive valve repair reduces heart failure hospitalizations in patients with severe tricuspid regurgitationAt two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available medical therapy plus a minimally invasive procedure using a clip to repair ...
After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results